Lightpoint Medical announced that it has appointed Graeme Smith to the position of CEO. Smith will focus on the commercialization of the company's recently approved miniaturized surgical probe, Sensei.
As executive chair, Dr. David Tuch, Lightpoint's CEO since founding the company, will work closely with Graeme through the transition and focus on scientific and technical leadership, corporate partnerships, and future growth opportunities.
Graeme has nearly three decades of experience at global medical device companies. Most recently Graeme led OstomyCure, a medical device company developing technology to treat inflammatory bowel diseases. He will continue to serve OstomyCure as nonexecutive chair.
Lightpoint's executive leadership team includes Claire Woodthorpe, who remains as chief operations officer, and new hires including heads of commercial operations, clinical, and manufacturing.
